Draig Therapeutics to Initiate Phase 2 Study of DT...
Category : Clinical Trial Update 6 October 2025Draig Therapeutics (Draig), a clinical-stage biotechnology company developing novel therapies for ne...
Clinical Trial Update
WHO Highlights Urgent Gaps in Antibacterial R&D an...
Category : Clinical Trial Update 6 October 2025The World Health Organization (WHO) released updated reports on antibacterial agents in clinical and...
Avobis Bio’s AVB-114 Receives FDA RMAT Designation...
Category : Clinical Trial Update 6 October 2025Avobis Bio LLC, a clinical-stage company developing implantable cell therapies, announced that the U...
Sitryx Therapeutics Receives FDA Clearance for Pha...
Category : Clinical Trial Update 6 October 2025Sitryx Therapeutics, a clinical-stage biopharmaceutical company developing novel oral therapies to r...
CollPlant announces positive results from non-clin...
Category : Clinical Trial Update 3 October 2025CollPlant Biotechnologies, a regenerative and aesthetic medicine company developing disruptive techn...
Latest Newsletter Post
-
Sitryx Therapeutics Receives FDA Cl..
6 October 2025
-
Avobis Bio’s AVB-114 Receives FDA R..
6 October 2025
-
WHO Highlights Urgent Gaps in Antib..
6 October 2025
-
Draig Therapeutics to Initiate Phas..
6 October 2025
-
LANDMARK PHASE 3 TRIAL (VESALIUS-CV..
3 October 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com